Call for Collaborator(s): Pfizer RSVOA Research

Pfizer is seeking applications for a $500,000 grant to identify investigators with innovative research proposals who are interested in partnering with Pfizer and potentially other likeminded investigators on co-developing research studies focused on the respiratory syncytial virus (RSV) vaccine (Pfizer – Abrysvo) in adults (RSV).